Hover a dot or row, or tab through the dots · bars scaled to the largest round ($763M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-565058
First filed2025-11-25
Latest2025-11-25
Sought$763M
Sold$763M
Investors234
Exemptions506(c)
Who backs Par Health, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-11-25
Related persons
Name
Relationship
Stephen Welch
RelationshipExecutive Officer, Director
Jack Boyle
RelationshipExecutive Officer
Andrew Gonce
RelationshipExecutive Officer
Kass Harrold
RelationshipExecutive Officer
Jake Longenecker
RelationshipExecutive Officer
Matthew Maletta
RelationshipExecutive Officer
Mick McGuinness
RelationshipExecutive Officer
Teresa Sanzottera
RelationshipExecutive Officer
Scott Sims
RelationshipExecutive Officer
Jeffrey Wiegers
RelationshipExecutive Officer
Michael Heffernan
RelationshipDirector
Joshua Murray
RelationshipDirector
Matthew Stober
RelationshipDirector
Jonathan Zinman
RelationshipDirector
Facts
As its latest Form D states them
Industry
Pharmaceuticals
State
Missouri (MO)
Exemptions
Rule 506(c)
First filed
2025-11-25
Latest filing
2025-11-25
Who backs Par Health, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)